[Tumor plasminogen activators and their clinical significance].
By means of a radio-immunological method the amount of plasminogen activators released by tumours was determined. The concentrations of tumour plasminogen activators was considerably higher in the venous blood of ovarial tumours than in the peripheral blood. In the uterine fluid the uterus cavity the concentration of plasminogen activator was increased in cases with neoplastic endometrium compared to those with normal endometrium.
D003536:Cystadenocarcinoma / Q000378:metabolism; D004717:Endometrium / Q000378:metabolism; D004789:Enzyme Activation; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D010051:Ovarian Neoplasms / Q000378:metabolism*; D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator / Q000097:blood
D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator
Tumorplasminogen-Aktivatoren und ihre klinische Bedeutung.